Market Constraints Affecting US Personalized WGS Market
RNCOS research report entitled “US Personalized Cancer Genome Sequencing Market”, says that Whole Genome sequencing technology encompasses huge revenue generation and is much more efficient as far as personalized treatment is concerned. Though WGS method is technologically more advanced as there is a huge cost incorporated with it. Few of the private players are consistently charging different prices based on sequencers and tools required for sequencing. It has also become difficult for the patients to bear out of the pocket...
View full press release